Compare GHM & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHM | OLMA |
|---|---|---|
| Founded | 1936 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1994 | 2020 |
| Metric | GHM | OLMA |
|---|---|---|
| Price | $101.11 | $10.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $73.33 | $44.89 |
| AVG Volume (30 Days) | 158.0K | ★ 1.0M |
| Earning Date | 06-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.90 | ★ 15.00 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $245,293,000.00 | N/A |
| Revenue This Year | $14.54 | N/A |
| Revenue Next Year | $18.23 | N/A |
| P/E Ratio | $303.00 | ★ N/A |
| Revenue Growth | ★ 16.86 | N/A |
| 52 Week Low | $46.58 | $5.36 |
| 52 Week High | $125.82 | $36.26 |
| Indicator | GHM | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 43.61 |
| Support Level | $88.36 | $10.71 |
| Resistance Level | $112.09 | $12.37 |
| Average True Range (ATR) | 5.25 | 0.57 |
| MACD | -0.48 | -0.03 |
| Stochastic Oscillator | 27.25 | 40.64 |
Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.